About Naslund Medical

placeholder

Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with subsidiaries in the U.S. and France and with contracted distributors on a global level.

The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Therapy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years, where he was one of the inventors of the SBRT technique in 1991 together with Ingmar Lax and Henric Blomgren.

The Karolinska University Hospital was ranked #6 best hospital in the world 2023 by Newsweek

 

We are happy to announce that for the third year in a row we have been recognized as one of the fastest growing companies in Sweden, awarded with the DI Mästargasell prize!

Thank you, all Gold Anchor users and distributors! We have made great progress in improving radiotherapy treatments together.

mastargasell
Swecare Export Award 2019

Naslund Medical has been awarded 2019 year’s Swecare Export Award for its innovation power, strategy and strong exports. We are grateful, proud and happy to be part of improving cancer care throughout the world.

Link to Swecare Export Award 2019 (text in Swedish).

Partnership with academia & healthcare

Swedish Testbed for Innovative Radiotherapy

Naslund Medical is one of the partners in a consortium aiming at establishing a Swedish testbed for innovative radiotherapy. The testbed will allow healthcare and industry to test new technology and new methods in clinical settings – and jointly drive the development of cancer treatment with radiation therapy. Learn more >

gentletherapy

Gentle Radiotherapy

Since all cancer treatment have adverse effects on the patient, we have to do it right the first time for every individual patient, this increases the chance of cure without harming the patient – “Gentle therapy”.

Naslund Medical is one of the business partners in a consortium consisting of all teaching hospitals associated with academia and 7 important industrial companies. The long-term goal is to create a large-scale national world class platform for cancer treatment. Learn more >

gentle-radiotherapy

Quality Management System

Naslund Medical AB is certified to SS-EN ISO 13485:2016 and according to the Directive 93/42/EEC on Medical Devices, Annex II, Full Quality Assurance System.

mail sign

Subscribe to our newsletter

Do you want to keep updated about Gold Anchor? Product development, exhibitions, testimonials. Sign up for our newsletter.

By clicking Subscribe, you agree to that you have read our Privacy Policy including Cookies.